Ibex Tech (IBT)
Ibex Tech is related to 1 other symbol. To date we've encountered 32 releases involving Ibex Tech.
Last Price: 0.028 (+0.003) - 11/7/2008,
3:03am
- Open: 0.028
- High: 0.027
- Low: 0.027
Ibex Tech Options
- Ibex Tech "Business Partners"
- Ibex Tech Press Releases
- Ibex Tech News
- Ibex Tech Contact
- Ibex Tech Related (via TRYNT)
Ibex Tech "Business Partners"
A "business partner" is defined as a third party company that has co-released at least one press release with Ibex Tech.
Ibex Tech Press Releases
- IBEX TECHNOLOGIES INC.: IBEX Comments on TSX Review (Trackbacks) (Backlinks), Tue, 24 Oct 2006 11:57:00 PDT
MONTREAL, QUEBEC (MARKET WIRE)
- IBEX Technologies Inc.: IBEX Reports Fiscal 2006 Financial Results (Trackbacks) (Backlinks), Thu, 28 Sep 2006 5:00:00 PDT
MONTREAL, QUEBEC (MARKET WIRE) IBEX Technologies Inc. (TSX: IBT), an innovator in the development of diagnostics for the management of cancer and arthritis, and a supplier of high-purity glycobiology enzymes, today reported its financial results for the fourth quarter and fiscal year ended July 31, 2006.
- Ibex Technologies Inc.: Ibex Reports Sales Revenue Increase of 23% for the Quarter and 33% for the Nine Month Period (Trackbacks) (Backlinks), Fri, 9 Jun 2006 6:15:00 PDT
MONTREAL, QUEBEC (MARKET WIRE) IBEX Technologies Inc. (TSX: IBT), an innovator in the development of diagnostics for the management of cancer and arthritis, and a supplier of high-purity glycobiology enzymes, today reported its financial results for the third quarter and nine-months ended April 30, 2006.
- Ibex Technologies Inc.: IBEX Re-Appoints Robert Heft to Ibex Board (Trackbacks) (Backlinks), Mon, 15 May 2006 5:00:00 PDT
MONTREAL, QUEBEC (MARKET WIRE) IBEX Technologies Inc. (TSX:IBT), an innovator in the development of diagnostics and therapeutics for the management of cancer and arthritis, today announced that the Board of Directors has elected Robert Heft, PhD as director.
- IBEX TECHNOLOGIES INC.: Patent Allowed on Therapeutic and Diagnostic Use for IBEX Human Kallikrein 15 (Trackbacks) (Backlinks), Tue, 2 May 2006 5:00:00 PDT
MONTREAL, QUEBEC (MARKET WIRE) IBEX Technologies Inc. (TSX:IBT), an innovator in the development of diagnostics and therapeutics for the management of cancer and arthritis, today announced that the European Patent Office has given notice of allowance of the human kallikrein 15 (hK15) patent, which is licensed to IBEX from Mt. Sinai Hospital (Toronto).
Ibex Tech News
- We have not detected any news yet.
Ibex Tech Contact
Contacts: IBEX Technologies Inc. Paul Baehr President & CEO (514) 344-4004 pbaehr@ibex.ca LaVoie Group Bryan P. Murphy Director, Public Relations (781) 596-0200 X 105 bmurphy@lavoiegroup.com
TRYNT Related
- Ibex Tech (IBT.SG)
- Ibex Tech (IBT.BE)
- Ibex Tech (IBT.DE)
- Ibex Tech (IBT.F)
- Ibex Technologies Inc (Tier1) (IBT.V)
- Ibt (2897.TWO)
- Ibt (IBT.BR)
- Ibt (IBY.SG)
- Intl Biotech Tst (IBT.VX)
- Intl Biotech Tst (IBT.L)
What is a Stock Cloud?
A Stock Cloud is a tag cloud like display of stock ticker symbols. The larger the ticker symbol the more frequent that company distributes press releases.